Keynote 859 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keynote 859 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keynote 859 Trial Today - Breaking & Trending Today

European Commission Approves New Frontline Indications for Pembrolizumab Plus Chemo in Select GI Cancers

The European Commission has approved new indications for pembrolizumab in combination with chemotherapy in select patients with gastric or gastroesophageal adenocarcinoma and select patients with biliary tract cancer. ....

European Union , European Commission , Merck Research Laboratories , Eligibility Criteria , Gastric Cancer , Gastroesophageal Cancer , Biliary Tract Carcinoma , Gi Cancers , Gastrointestinal Cancers , Keynote 859 Trial , Keynote 966 Trial ,